| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/11/2002 | WO2001053348A3 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them |
| 04/11/2002 | WO2001036616A3 Acid nucleic construct bearing a system regulating the expression of a gene |
| 04/11/2002 | WO2001036374A3 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments |
| 04/11/2002 | WO2001032680A3 18-nor-steroids as selectively active estrogens |
| 04/11/2002 | WO2001024782A3 Pharmaceutical agent for the treatment of cachexia and/or cardiogenic shock |
| 04/11/2002 | WO2000038518A9 Efficient and stable (in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors |
| 04/11/2002 | US20020042554 Cardiac disease treatment method |
| 04/11/2002 | US20020042515 Tetrahydroquinolines |
| 04/11/2002 | US20020042505 Novel human ion channel protein and polynucleotides encoding the same |
| 04/11/2002 | US20020042444 Treatment of lipid metabolic disorders using 5-(1,2-dithiolan-3-yl) valeric acid (alpha-lipoic acid) or its physiologically compatible salts |
| 04/11/2002 | US20020042443 Estrogen agonist / antagonist metabolites |
| 04/11/2002 | US20020042441 N-substituted indoles useful in the treatment of diabetes |
| 04/11/2002 | US20020042435 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/11/2002 | US20020042421 Antiinflammatory agents |
| 04/11/2002 | US20020042415 Dipeptide derivatives |
| 04/11/2002 | US20020042405 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure |
| 04/11/2002 | US20020042400 Antihistamines |
| 04/11/2002 | US20020042385 Cloning of a novel 7TM receptor AXOR-2 |
| 04/11/2002 | US20020042381 Antilipemic agents |
| 04/11/2002 | US20020042376 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 04/11/2002 | US20020042372 Genetic engineering; central nervous system disorders |
| 04/11/2002 | US20020042368 Integrin antagonists |
| 04/11/2002 | US20020042101 Nucleotide sequences which code enzymatic polypeptide for use in the treatment of cancer, restenosis and diabetic neuropathy |
| 04/11/2002 | US20020042091 Methods and compositions for screening modulators of lipid kinases |
| 04/11/2002 | US20020042086 Activating vascular system propagation; for use in the treatment of repefusion injury and bronci defects |
| 04/11/2002 | US20020041894 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis and pharmaceutical compositions and kit related thereto |
| 04/11/2002 | US20020041878 Monitoring angiogenesis factor |
| 04/11/2002 | US20020041876 Modulation of angiogenesis |
| 04/11/2002 | DE10047486A1 Phenoxyphenyl Alkansulfonate Phenoxy-phenyl alkane |
| 04/11/2002 | DE10046993A1 Substituierte Zimtsäureguanidide, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltendes Medikament Substituted Zimtsäureguanidide, processes for their preparation, their use as a medicament and they drug-containing |
| 04/11/2002 | CA2425269A1 G-protein coupled receptors |
| 04/11/2002 | CA2425266A1 Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension |
| 04/11/2002 | CA2425152A1 Highly expressible genes |
| 04/11/2002 | CA2425126A1 Lipid metabolism enzymes |
| 04/11/2002 | CA2425097A1 Benzamide compounds as apo b secretion inhibitors |
| 04/11/2002 | CA2424761A1 Method of treating cancer using dithiocarbamate derivatives |
| 04/11/2002 | CA2424693A1 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases |
| 04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | CA2424620A1 Inhalation particles incorporating a combination of two or more active ingredients |
| 04/11/2002 | CA2424604A1 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | CA2424581A1 Compounds useful for treating hypertriglyceridemia |
| 04/11/2002 | CA2424506A1 Cyclopeptides, a method for their preparation and their use as inhibitors or activators of angiogenesis |
| 04/11/2002 | CA2424222A1 Inhibitors of prenyl-protein transferase |
| 04/11/2002 | CA2424216A1 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | CA2424117A1 Phosphoric acid salt of an integrin receptor antagonist |
| 04/11/2002 | CA2423929A1 Carbohydrate-associated proteins |
| 04/11/2002 | CA2423898A1 Ethers of 7-desmethylrapamycin for use in immunosuppression |
| 04/11/2002 | CA2423888A1 Hydroxyesters of 7-desmethylrapamycin |
| 04/11/2002 | CA2423883A1 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 04/11/2002 | CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | CA2423656A1 Methods and compositions for enhancing angiogenesis |
| 04/11/2002 | CA2423462A1 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | CA2423312A1 Condensed pyridoindole derivatives |
| 04/11/2002 | CA2422810A1 New oxabispidine compound useful in the treatment of cardiac arrhythmias |
| 04/11/2002 | CA2421782A1 Quinoline and quinolinone derivatives as metabotropic glutamate receptor antagonists |
| 04/11/2002 | CA2421776A1 New process for the production of oxabispidines |
| 04/11/2002 | CA2421417A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 04/10/2002 | EP1195605A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195604A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195378A1 Pyridotriazines and pyridopyridazines |
| 04/10/2002 | EP1195372A1 N-heterocyclic substituted benzamide derivatives with antihypertensive activity |
| 04/10/2002 | EP1195166A2 Use of a vasopressin antagonist such as conivaptan in the manufacture of a medicament for treating pulmonary hypertension |
| 04/10/2002 | EP1195160A1 Sustained release trimetazidine pharmaceutical compositions and a method of their preparation |
| 04/10/2002 | EP1194595A1 Polymorphisms in the human hmg-coa reductase gene |
| 04/10/2002 | EP1194584A1 Method for producing oligopolysaccharides |
| 04/10/2002 | EP1194566A2 Gene therapy for enhancing and/or inducing angiogenesis |
| 04/10/2002 | EP1194528A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 04/10/2002 | EP1194448A1 Seven transmembrane receptor genes |
| 04/10/2002 | EP1194447A2 Novel potassium channels and genes encoding these potassium channels |
| 04/10/2002 | EP1194443A1 Cysteinyl protease inhibitors |
| 04/10/2002 | EP1194441A2 Thiophene a2a receptor agonists |
| 04/10/2002 | EP1194440A2 Induction of pharmacological stress with adenosine receptor agonists |
| 04/10/2002 | EP1194439A1 Human eag2 |
| 04/10/2002 | EP1194429A1 Potassium channel openers |
| 04/10/2002 | EP1194425A1 Substituted benzimidazole |
| 04/10/2002 | EP1194421A1 Selective npy (y5) antagonists |
| 04/10/2002 | EP1194411A1 Benzoylpyridazines |
| 04/10/2002 | EP1194403A1 Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same |
| 04/10/2002 | EP1194401A1 Diacylhydrazine derivatives |
| 04/10/2002 | EP1194186A2 CARDIOACTIVE COMPOSITION COMPRISING L-CARNITINE AND ITS DERIVATIVES AND i CRATAEGUS /i EXTRACTS |
| 04/10/2002 | EP1194173A1 X-ray guided drug delivery |
| 04/10/2002 | EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 04/10/2002 | EP1194151A1 Integrin receptor antagonists |
| 04/10/2002 | EP1194147A1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 04/10/2002 | EP1194145A2 Stable xylometazoline and oxymetazoline solution |
| 04/10/2002 | EP1194143A2 Il-8 receptor antagonists |
| 04/10/2002 | EP1194140A1 Pharmaceutical composition containing fenofibrate and preparation method |
| 04/10/2002 | EP1030845B1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 04/10/2002 | EP0950046B1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 04/10/2002 | EP0948478B1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 04/10/2002 | EP0927150B1 Lipoxin compounds and their use in treating cell proliferative disorders |
| 04/10/2002 | EP0912567B1 Carboline derivatives |
| 04/10/2002 | EP0901499B1 Adenosine derivatives |
| 04/10/2002 | EP0732329B1 Chroman derivative |
| 04/10/2002 | EP0712402B1 Hydroisoquinoline derivatives |
| 04/10/2002 | CN1344326A Petroviral vectors comprising functional and non-functional splice donor and splce acceptor sites |
| 04/10/2002 | CN1344274A Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/10/2002 | CN1344268A Use of imidazo [1,5-a]pyrido[3,2-e]-pyrazinones as medicaments |
| 04/10/2002 | CN1344267A Substituted 1-(pieridin-4-Yl)-3-(aryl) isothioureas their prepn. and therapeutic application |